It has been shown in the context of glioblastoma that cross-inhibitory regulation between the MAPK and PI3K/mTOR pathways by p70S6K contributes to both tumorigenic and self-renewal capacity of cancer stem-like cells [22]. The gene discussed is MTOR; the disease is cancer.